<div id="readability-page-1"><article><ul><li>Strategic Partnership: Creatd expanded Fly Flyte’s investor network by adding NYSE-listed VTAK as an investor in its subsidiary.</li><li>Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions. </li><li>Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. </li></ul> NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc. (NYSE American: VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd’s strategy of nurturing technology-enabled subsidiaries with scalable infrastructure and long-term value creation potential while maintaining Fly Flyte’s operational independence and strategic focus. Creatd welcomes VTAK as a partner in Flyte’s continued growth and success. “Creatd is committed to building a portfolio of operating companies in the small-cap space,” said Jeremy Frommer, CEO of Creatd, Inc. “We see an opportunity to address the white space created by the contraction of middle markets over the last two decades. By integrating capabilities from banking, investing, advisory, branding, investor relations, financial analysis, and operational leverage, we can build a foundation of interlinked services to support growth-driven companies and provide pathways for them to scale or transition to listed entities.” Fly Flyte is operational today, providing AI-enabled regional aviation services designed to increase accessibility and convenience. The company leverages certified aircraft, established routes, and scalable infrastructure to deliver real-time revenue while positioning for long-term expansion. About Creatd: Creatd, Inc. (OTCQB: CRTD) acquires and grows technology-driven companies in aviation, media, and advisory services. Through its shared services model, Creatd enables its portfolio companies to scale efficiently, improve margins, and expand market reach. For more information, visit www.creatd.com. Contact: ir@creatd.com Forward-Looking Statements: This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include all statements, other than statements of historical fact, regarding our current views and assumptions with respect to future events regarding our business and our expectations with respect to the completion of the offering, the satisfaction of customary closing conditions related to the offering and the additional closings, the anticipated use of proceeds therefrom, and other statements that are predictive in nature. These statements can be identified often, but not always, through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects,” and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Such factors and risks include, among others, market and other risks, that the additional closings after today may not occur if certain closing conditions are not met, and that there can be no assurance that the Company will successfully uplist to a national securities exchange. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release contains forward-looking statements and is qualified in its entirety by, and should be read together with, the cautionary statements, risk factors and other disclosures contained in the Company’s filings with the SEC and OTC Markets. <img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMU5qRXdOaU0zTkRNd01UazFJelV3TURFek16SXlOdz09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMU5qRXdOaU0zTkRNd01UazFJelV3TURFek16SXlOdz09"/> <img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NThkM2NjNTctYjU3MS00OGJhLTgyZWMtM2FiZDkyY2QxZjQ3LTUwMDEzMzIyNy0yMDI2LTAyLTE3LWVu/tiny/CREATD-INC-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NThkM2NjNTctYjU3MS00OGJhLTgyZWMtM2FiZDkyY2QxZjQ3LTUwMDEzMzIyNy0yMDI2LTAyLTE3LWVu/tiny/CREATD-INC-.png"/></article></div>

CRTD

SCHA

Creatd, Inc. announced that Catheter Precision, Inc. (VTAK) has acquired a 20% equity interest in its subsidiary, Fly Flyte, Inc. This strategic partnership aims to enhance Fly Flyte's investor network and aligns with Creatd's strategy of nurturing technology-enabled subsidiaries. Fly Flyte is focused on transforming regional aviation through innovative, AI-enabled services. Creatd's CEO emphasized the company's commitment to building a portfolio of small-cap operating companies, leveraging integrated capabilities to support growth and scalability.

StockTitan

Creatd, Inc.

VG S-Cp

Schw Us S-Cp

ARK Space Exploration & Innovation ETF

Catheter Precision

VG S-Cp Grw

T.Rowe Price Small-Mid Cap ETF

Invesco Aero & Defense ETF

SPDR S&P Aerospace & Def

ISHRS Aero & Def

CREATD INC

VTAK Acquires 20% Interest in Creatd’s Subsidiary Fly Flyte, Inc. | CRTD Stock News